{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:10:46Z","timestamp":1788606646401,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-003628"],"award-info":[{"award-number":["INV-003628"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007037"],"award-info":[{"award-number":["BBS\/E\/I\/00007037"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007039"],"award-info":[{"award-number":["BBS\/E\/I\/00007039"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.08.088","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:10:49Z","timestamp":1694254249000},"page":"6572-6578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of a quadrivalent foot-and-mouth disease vaccine candidate for use in East Africa"],"prefix":"10.1016","volume":"41","author":[{"given":"Kay","family":"Childs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Woma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Wilsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-6533","authenticated-orcid":false,"given":"Hualu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-9830","authenticated-orcid":false,"given":"Julian","family":"Seago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2023.08.088_b0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11259-022-09899-3","article-title":"Diversity of SAT2 foot-and-mouth disease virus in Sudan: implication for diagnosis and control","volume":"46","author":"A\/Raouf","year":"2022","journal-title":"Vet Res Commun"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.088_b0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.meegid.2010.06.017","article-title":"Diversity and transboundary mobility of serotype O foot-and-mouth disease virus in East Africa: implications for vaccination policies","volume":"10","author":"Balinda","year":"2010","journal-title":"Infect Genet Evol"},{"issue":"49","key":"10.1016\/j.vaccine.2023.08.088_b0015","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1016\/j.vaccine.2017.10.040","article-title":"Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain","volume":"35","author":"Lloyd-Jones","year":"2017","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2023.08.088_b0020","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1016\/j.vaccine.2014.08.033","article-title":"Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains","volume":"32","author":"Bari","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.088_b0025","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00705-020-04662-y","article-title":"A vaccine-matching assessment of different genetic variants of serotype O foot-and-mouth disease virus isolated in Ethiopia between 2011 and 2014","volume":"165","author":"Tesfaye","year":"2020","journal-title":"Arch Virol"},{"issue":"35","key":"10.1016\/j.vaccine.2023.08.088_b0030","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.vaccine.2021.07.001","article-title":"The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa","volume":"39","author":"Jackson","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.088_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31856-x","article-title":"Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate","volume":"8","author":"Kotecha","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.08.088_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/v13091830","article-title":"Targeted FMD vaccines for Eastern Africa: The AgResults foot and mouth disease vaccine challenge project","volume":"13","author":"Hammond","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.088_b0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/v14030621","article-title":"An improved \u03b1v\u03b26-receptor-expressing suspension cell line for foot-and-mouth disease vaccine production","volume":"14","author":"Harvey","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.08.088_b0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-2836(83)80282-4","article-title":"Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements","volume":"166","author":"Dunn","year":"1983","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.088_b0055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1099\/jgv.0.000462","article-title":"Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation","volume":"97","author":"Kotecha","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2023.08.088_b0060","unstructured":"OIE. Foot-and-Mouth Disease, Manual of Diagnostic... - Google Scholar n.d. https:\/\/scholar.google.com\/scholar?hl=en&as_sdt=0%2C5&q=OIE.+Foot-and-Mouth+Disease%2C+Manual+of+Diagnostic+Tests+and+Vaccines+for+Terrestrial+Animals%3A+Mammals%2C+Birds%2C+and+Bees.+Paris%3B+2012.&btnG= [accessed May 10, 2023]."},{"issue":"10","key":"10.1016\/j.vaccine.2023.08.088_b0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat Struct Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T17:06:29Z","timestamp":1736442389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2301054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":13,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X2301054X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a quadrivalent foot-and-mouth disease vaccine candidate for use in East Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}